RAPID receives registration approval in Japan
advertisement
Current Location:
>
>
> This Story

Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Health IT Homepage

XSOLIS partners with AdventHealth for data-driven utilization management

Margaret West Comprehensive Breast Center selects Ikonopedia for structured breast reporting and risk assessment

Healthcare IT solutions provider, Comport explains the benefits of cloud object storage for healthcare

Holon Solutions awarded second U.S. patent this year targeted at solving healthcare interoperability

DrChrono and OutcomeMD announce partnership making it easier to track and analyze patient outcome data and confounding factors

Study of top U.S. health systems finds patient billing and revenue cycle management improvement, but multiple challenges ahead

The SyMRI NEURO software from SyntheticMR AB now available on syngo.via open apps from Siemens Healthineers in U.S.

NetDirector cloud-based PDF to DICOM conversion is live with American Health Imaging and continues to expand

CynergisTek sees increased demand for medical device security services in first year of deployment

Kent Diagnostic Radiology contracts with Healthcare Administrative Partners for comprehensive revenue cycle services

RAPID receives registration approval in Japan

Press releases may be edited for formatting or style
MENLO PARK, Calif.--(BUSINESS WIRE)--iSchemaView, the worldwide leader in advanced imaging for stroke, has received registration approval under the Japanese Pharmaceutical Affairs Law through third party review by the Japanese Association for the Advancement of Medical Equipment for its RAPID imaging platform. With this news the technology is available to hospitals across Japan, with the support of Micron, the Japanese RAPID distributor. RAPID is designed to provide physicians with fast, fully automated, and easy-to-interpret imaging that facilitates clinical decision-making around stroke.

“Stroke remains the fourth most common cause of death in Japan, and as the population ages, stroke is likely to become an increasing health burden on the country,” said Dr. Manabu Inoue from National Cerebral and Cardiovascular Center. “With RAPID’s AI-powered imaging technology we will be able to better address our patients to provide them with the best routes of care, improving their chances of recovery.”

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



Developed by leading stroke experts, RAPID technology has been selected for use in several ground-breaking trials that have changed treatment guidelines issued by both the American Heart Association and American Stroke Association. The RAPID Artificial Intelligence framework combines deep learning, machine learning and expert feature extraction. Together these provide unparalleled sensitivity and specificity across stroke modules (CT perfusion, MR diffusion and perfusion, CTA and CT ASPECT scoring). Results are then delivered by the RAPID Intelligence Services Platform via PACS, email, text, the RAPID app or corporate partner workflow systems.

The Complete RAPID Platform includes:

RAPID CTP: fully-automated perfusion maps; accurately quantifies reduced cerebral blood flow, cerebral blood volume and transit time
RAPID MRI: fully-automated diffusion and perfusion maps that quantify brain areas with low ADC values, as well as delayed contrast arrival
RAPID CTA: automatically delivers CT angiography maps and identifies brain regions with reduced blood vessel density in 2D and 3D outputs
RAPID ASPECTS: automatically identifies areas of early ischemic change on non-contrast CT scans, which predicts irreversible injury
RAPID Mobile App: Securely review RAPID results from multiple sites with customizable notifications

“With approval for RAPID in Japan, we extend a global footprint that gives more hospitals the tools they need to help stroke patients achieve the best outcomes and quality of life,” said Anil Singhal, MD, SVP, Worldwide Operations at iSchemaView. “Our goal is to help as many stroke patients as possible by delivering the only clinically validated, next-generation imaging technology available.”
  Pages: 1 - 2 >>

Health IT Homepage


You Must Be Logged In To Post A Comment